Location: New York, NY
CIK: 0002054410 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $366M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 1,131,500 | $80.39M | 21.9% | — | — | COM | 156944100 |
| URGN | UROGEN PHARMA LTD | 1,673,420 | $61.58M | 16.8% | — | — | COM | M96088105 |
| TRVI | TREVI THERAPEUTICS INC | 2,144,844 | $40M | 10.9% | — | — | COM | 89532M101 |
| CADL | CANDEL THERAPEUTICS INC | 3,497,948 | $36.03M | 9.8% | — | — | COM | 137404109 |
| PBYI | PUMA BIOTECHNOLOGY INC | 4,131,299 | $33.5M | 9.1% | — | — | COM | 74587V107 |
| JBIO | JADE BIOSCEINCES INC | 986,760 | $21.93M | 6.0% | — | — | COM NEW | 008064206 |
| BCAX | BICARA THERAPEUTICS | 643,381 | $19.1M | 5.2% | — | — | COM | 055477103 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 1,518,113 | $14.83M | 4.0% | — | — | COMMON STOCK | 48576U205 |
| OKUR | ONKURE THERAPEUTICS INC | 2,839,674 | $12.95M | 3.5% | — | — | CLASS A COM | 68277Q105 |
| HELP | HELUS PHARMA INC. | 1,540,266 | $10.18M | 2.8% | — | — | COM STK | 23256X407 |
| TARA | PROTARA THERAPEUTICS INC | 1,752,115 | $6.693M | 1.8% | — | — | COM STK | 74365U107 |
| AURA | AURA BIOSCIENCES INC | 929,077 | $6.596M | 1.8% | — | — | COM | 05153U107 |
| LONA | LEONABIO, INC. | 634,539 | $5.831M | 1.6% | — | — | COMMON STOCK | 04746L203 |
| VSTM | VERASTEM INC | 1,469,153 | $5.612M | 1.5% | — | — | COM | 92337C203 |
| WHWK | WHITEHAWK THERAPEUTICS INC | 1,139,363 | $5.218M | 1.4% | — | — | COM | 00032Q104 |
| QTTB | Q32 BIO INC. | 216,171 | $2.754M | 0.8% | — | — | COM | 746964105 |
| ENGN | EUGENE THERAPEUTICS | 1,271,257 | $2.199M | 0.6% | — | — | COM | 29286X101 |
| JSPR | JASPER THERAPEUTICS | 1,438,159 | $604K | 0.2% | — | — | COM | 471871202 |
| BCAB | BIOATLA INC | 108,126 | $448K | 0.1% | — | — | COM | 09077B104 |
| VYNE | VYNE THERAPEUTICS INC | 1,425 | $926 | 0.0% | — | — | COM | 92941V308 |